Coinfection with the hepatitis viruses is common in the HIV population in sub-Saharan Africa. The aim of this study was to assess, in a cohort of HIV-infected pregnant women receiving antiretroviral drugs (ARVs), the prevalence of HBV and HCV infections and to determine the impact of these infections on the occurrence of liver toxicity and on the viro-immunological response.
Andreotti, M., Pirillo, M., Liotta, G., Jere, H., Maulidi, M., Sagno, J., et al. (2014). The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi. BMC INFECTIOUS DISEASES, 14, 180 [10.1186/1471-2334-14-180].
The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi
LIOTTA, GIUSEPPE;PALOMBI, LEONARDO;MANCINELLI, SANDRO
2014-01-01
Abstract
Coinfection with the hepatitis viruses is common in the HIV population in sub-Saharan Africa. The aim of this study was to assess, in a cohort of HIV-infected pregnant women receiving antiretroviral drugs (ARVs), the prevalence of HBV and HCV infections and to determine the impact of these infections on the occurrence of liver toxicity and on the viro-immunological response.| File | Dimensione | Formato | |
|---|---|---|---|
|
The impact of HBV or HCV Infection on Safety and Efficacy of Antiretroviral Drugs in a Cohort of 1471-2334-14-180.pdf
accesso aperto
Descrizione: Articolo elettronico
Dimensione
547.53 kB
Formato
Adobe PDF
|
547.53 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
